HIGHLIGHTS
- who: . and collaborators from the Sichuan University, China have published the research: Do antibody drug conjugates increase the risk of sepsis in cancer patients? A pharmacovigilance study, in the Journal: (JOURNAL)
- what: The aim of this study was to identify the association between ADCs and sepsis using FAERS data and uncover the clinical characteristics of ADCrelated sepsis. Males showed significantly higher safety concern for sepsis than females; however, age did not correlate with ADC-related Meanwhile, the first case of sepsis (Schaefer et_al, 2014) correlated with brentuximab vedotin was reported in 2014, and there have . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.